TARDBP and amyotrophic lateral sclerosis: Compared to wild-type TDP-43 mice, overexpression of mutant TDP-43 leads to a worsened dose-dependent ALS-FTLD-like phenotype in terms of motor dysfunction and lethality, neurodegeneration, and gliosis as well as development of phosphorylated TDP-43 cytoplasmic granules.